Clinical Trials Browser

Phase 4 × Multiple Myeloma × 30 days × Clear all

NCT05201781 2026-03-17

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Phase 4 Recruiting

Multiple Myeloma

NCT07474961 2026-03-16

BLOOD-dose

Phase 4 Not yet recruiting

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma